<!doctype html>
<!--[if IEMobile]><html class="iemobile" lang="en-gb"> <![endif]-->
<!--[if IE 7]>    <html class="no-js ie7 oldie" lang="en-gb"> <![endif]-->
<!--[if IE 8]>    <html class="no-js ie8 oldie" lang="en-gb"> <![endif]-->
<!--[if gt IE 8]><!-->  <html class="no-js" lang="en-gb"> <!--<![endif]-->

<head>
 <script type="text/javascript" src="/templates/vp_promart/js/template.js.php?v=1.0.6"></script>
   <base href="https://pipelinereview.com/index.php/2020081175554/DNA-RNA-and-Cells/FDA-Approves-American-Gene-Technologies-AGT-to-Move-Forward-with-Phase-1-Clinical-Trial-of-HIV-Cure-Program.html" />
  <meta http-equiv="content-type" content="text/html; charset=utf-8" />
  <meta name="keywords" content="Biologics, DNA, gene therapy, RNA, siRNA, RNAi, antisense, oligonucleotides, cells, cell therapy, stem cells " />
  <meta name="robots" content="index, follow" />
  <meta name="author" content="Ulrich Martin" />
  <meta name="description" content="FDA Approves American Gene Technologies (AGT) to Move Forward with Phase 1 Clinical Trial of HIV Cure Program" />
  <title>FDA Approves American Gene Technologies (AGT) to Move Forward with Phase 1 Clinical Trial of HIV Cure Program | DNA RNA and Cells | News Channels</title>
  <link href="/templates/vp_promart/favicon.ico" rel="shortcut icon" type="image/vnd.microsoft.icon" />
  <link href="https://pipelinereview.com/index.php/search.html?catid=17&amp;format=opensearch&amp;id=75554&amp;lang=en" rel="search" title="Search PipelineReview.com" type="application/opensearchdescription+xml" />
  <link rel="stylesheet" href="/plugins/system/cookiemonster/assets/css/cm_gradblack.css" type="text/css" />
  <link rel="stylesheet" href="/plugins/content/addthis/css/at-jp-styles.css" type="text/css" />
  <link rel="stylesheet" href="/media/system/css/modal.css" type="text/css" />
  <link rel="stylesheet" href="https://pipelinereview.com/templates/vp_promart/css/print.css" type="text/css" media="print"  />
  <link rel="stylesheet" href="/templates/vp_promart/css/template.css.php?s=4v=1.0.6" type="text/css" />
  <link rel="stylesheet" href="/components/com_virtuemart/assets/css/vmsite-ltr.css?vmver=8609" type="text/css" />
  <style type="text/css">
.vm-simple-product-slideshow.flexslider{background:#FFFFFF;}.promart .branding > .logo-link{background-image:url(/images/logo.png)}
  </style>
  <script src="/plugins/system/cookiemonster/assets/js/jquery.js" type="text/javascript"></script>
  <script src="/plugins/system/cookiemonster/assets/js/noconflict.js" type="text/javascript"></script>
  <script src="/plugins/system/cookiemonster/assets/js/cookiemonster.js" type="text/javascript"></script>
  <script src="/media/system/js/modal.js" type="text/javascript"></script>
  <script src="/media/system/js/mootools-more.js" type="text/javascript"></script>
  <script src="/templates/vp_promart/js/modernizr.js" type="text/javascript"></script>
  <script src="https://www.paypalobjects.com/webstatic/ppplus/ppplus.min.js" type="text/javascript"></script>
  <script type="text/javascript">
window.addEvent('load', function() {
				new JCaption('img.caption');
			});
		window.addEvent('domready', function() {

			SqueezeBox.initialize({});
			SqueezeBox.assign($$('a.modal'), {
				parse: 'rel'
			});
		});window.addEvent('domready', function() {
			$$('.hasTooltip').each(function(el) {
				var title = el.get('title');
				if (title) {
					var parts = title.split('::', 2);
					el.store('tip:title', parts[0]);
					el.store('tip:text', parts[1]);
				}
			});
			var JTooltips = new Tips($$('.hasTooltip'), { maxTitleChars: 50, fixed: false});
		});
  </script>
  <script type="text/javascript" src="https://s7.addthis.com/js/300/addthis_widget.js"></script>

 <!--[if lt IE 9]>
  <script src="https://html5shim.googlecode.com/svn/trunk/html5.js"></script>
 <![endif]--> 
 <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0" /> <!-- mobile viewport -->
 <link rel="apple-touch-icon-precomposed" href="/templates/vp_promart/apple-touch-icon-57x57.png"> <!-- iphone, ipod, android -->
 <link rel="apple-touch-icon-precomposed" sizes="72x72" href="/templates/vp_promart/apple-touch-icon-72x72.png"> <!-- ipad -->
 <link rel="apple-touch-icon-precomposed" sizes="114x114" href="/templates/vp_promart/apple-touch-icon-114x114.png"> <!-- iphone retina -->
 <!--[if lte IE 8]>
  <style> 
   {behavior:url(/templates/vp_promart/js/PIE.htc);}
  </style>
 <![endif]-->
 <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans">
  
  <meta name="google-site-verification" content="dsX08dikQ0X2kcu98OxE0ObN2cA9TXynkXt0llj1wJw" />
  <meta name="msvalidate.01" content="24023482B6AAD249C52DE3D14112B9D3" />
  <link rel="publisher" href="/ https://plus.google.com/u/3/106304522368326056409" />
  
  <meta name="geo.region" content="DE-BW" />
  <meta name="geo.placename" content="Weikersheim" />
  <meta name="geo.position" content="49.48134;9.900284" />
  <meta name="ICBM" content="49.48134, 9.900284" />
  
  <meta property="og:title" content="The Biologics News and Reports Portal">
  <meta property="og:site_name" content="pipelinereview">
  <meta property="og:url" content="https://pipelinereview.com">
  <meta property="og:description" content="La Merie Publishing prepares brief and full reports as well as competitor analysis reports, the latter in a tabulated format with structured listings of industry-relevant data. One of our top-selling.">
  <meta property="og:type" content="business.business">
  <meta property="og:image" content="https://pipelinereview.com/images/logo.png">

  <link href="https://pipelinereview.com/index.php/2020081175554/DNA-RNA-and-Cells/FDA-Approves-American-Gene-Technologies-AGT-to-Move-Forward-with-Phase-1-Clinical-Trial-of-HIV-Cure-Program.html" rel="canonical" />
  
</head>
  
<body class="promart style-4 " onunload="Session.Abandon();">
<!-- Facebook SDK -->
<div id='fb-root'></div>
<script type='text/javascript'>

      // Load the SDK Asynchronously
      (function(d){
      var js, id = 'facebook-jssdk'; if (d.getElementById(id)) {return;}
      js = d.createElement('script'); js.id = id; js.async = true;
      js.src = '//connect.facebook.net/en_GB/all.js';
      d.getElementsByTagName('head')[0].appendChild(js);
    }(document));

</script>
<!-- End Facebook SDK -->

  <div id="overall">
        <div id="top" class="top-bar container">
      <div class="row-fluid">
        <div class="span12 top-bar-cont">        
          
          <div class="language-currency-mod">
                          
              
          </div>
        </div>
        <div class="show-cart visible-phone">
                    <i class="icon-shopping-cart"></i><a class="phone-show-cart" href="/index.php/my-cart" title="Show Cart">Show Cart</a>
        </div>          
      </div>
    </div>
        
    <header id="header" class="container">
      <div class="row-fluid branding-header-module">
        <div class="span3 branding">
          <a class="logo-link" href="/">PipelineReview.com</a>
        </div>  
                 <div class="header-modules span7 hidden-phone center">      
          <ul class="side-menu-line">
<li class="item-544"><a href="http://www.pipelinereview.com" ><img src="/images/home.png" alt="Home" /><span class="image-title">Home</span> </a></li><li class="item-187"><a href="/index.php/my-cart" ><img src="/images/mycart.png" alt="My cart / Checkout" /><span class="image-title">My cart / Checkout</span> </a></li><li class="item-281"><a href="/index.php/contact-us-2" ><img src="/images/contact.png" alt="Contact Us" /><span class="image-title">Contact Us</span> </a></li></ul>
        
        </div>
        <div class="header-modules span2 hidden-phone">      
          

<div class="customlogo"  >
	<a href="http://www.lamerie.com/" target="_blank"><img src="/images/logo_lamerie.png" width="142" height="58" alt="La Merie Publishing" style="border: 0px solid #000000;" /></a></div>
      
        </div>  
                           
      </div>
            <div class="row-fluid">
        <div class="navbar navbar-inverse span12">
          <div class="navbar-inner">       
            <!-- .btn-navbar is used to toogle  collapsed navbar content -->
            <a class="btn btn-navbar" data-toggle="collapse" data-target=".nav-collapse">
              <span class="icon-bar"></span>
              <span class="icon-bar"></span>
              <span class="icon-bar"></span>
            </a>
            <div class="pull-right">
              
            </div>                        
            <!-- Everything you want hidden at 940px or less, place within here -->
            <div class="nav-collapse">
              <div class="pull-left visible-desktop" style="width:980px;">
                <nav>
<ul class="menu nav ">
<li class="item-101"><a href="/" >Home</a></li><li class="item-113 active deeper parent"><a href="/index.php/News-Channels/" >News Channels</a><ul class="submenu sublevel-1"><li class="item-121"><a href="/index.php/Table/News-Channels/Antibodies/" >Antibodies</a></li><li class="item-122 current active"><a href="/index.php/Table/News-Channels/DNA-RNA-and-Cells/" >DNA, RNA &amp; Cells</a></li><li class="item-123"><a href="/index.php/Table/News-Channels/Proteins-and-Peptides/" >Protein &amp; Peptides</a></li><li class="item-124"><a href="/index.php/Table/News-Channels/Small-Molecules/" >Small Molecules</a></li><li class="item-125"><a href="/index.php/Table/News-Channels/Vaccines/" >Vaccines</a></li><li class="item-126"><a href="/index.php/Table/News-Channels/More-News/" >More News</a></li></ul></li><li class="item-116 deeper parent"><a href="/index.php/reports" >Reports</a><ul class="submenu sublevel-1"><li class="item-974"><a href="/index.php/reports" >All Products</a></li><li class="item-1108"><a href="/index.php/reports/antibody-protein-sales" >Antibody &amp; Protein Sales</a></li><li class="item-1109"><a href="/index.php/reports/antibody-technologies" >Antibody Technologies</a></li><li class="item-1110"><a href="/index.php/reports/biosimilar-antibodies-proteins" >Biosimilar Antibodies &amp; Proteins</a></li><li class="item-1111"><a href="/index.php/reports/car-t-cells-nk-cells" >CAR T-Cells &amp; NK Cells</a></li><li class="item-1112"><a href="/index.php/reports/immuno-oncology" >Immuno-Oncology</a></li><li class="item-1118"><a href="/index.php/reports/mrna-vaccines-therapeutics" >mRNA Vaccines &amp; Therapeutics</a></li><li class="item-1113"><a href="/index.php/reports/pipeline-database" >Pipeline Database </a></li><li class="item-1114"><a href="/index.php/reports/target-pipelines" >Target Pipelines</a></li><li class="item-1115"><a href="/index.php/reports/tcr-t-cells-and-antibodies" >TCR T-Cells and Antibodies</a></li><li class="item-1116"><a href="/index.php/reports/therapeutic-proteins-peptides" >Therapeutic Proteins &amp; Peptides</a></li><li class="item-1117"><a href="/index.php/reports/vaccines" >Vaccines</a></li></ul></li><li class="item-1119"><a href="https://lamerie.com/free-reports-list/" >FREE reports</a></li><li class="item-277"><a href="/index.php/Offers.html" >Offers</a></li><li class="item-118"><a href="/index.php/Table/Press-Room/" >Press Room</a></li><li class="item-119"><a href="/index.php/2005120240/About-Us.html" >About Us</a></li></ul>
</nav>

              </div>
              <div class="hidden-desktop">
                <nav>
<ul class="menu nav ">
<li class="item-101"><a href="/" >Home</a></li><li class="item-113 active deeper parent"><a href="/index.php/News-Channels/" >News Channels</a><ul class="submenu sublevel-1"><li class="item-121"><a href="/index.php/Table/News-Channels/Antibodies/" >Antibodies</a></li><li class="item-122 current active"><a href="/index.php/Table/News-Channels/DNA-RNA-and-Cells/" >DNA, RNA &amp; Cells</a></li><li class="item-123"><a href="/index.php/Table/News-Channels/Proteins-and-Peptides/" >Protein &amp; Peptides</a></li><li class="item-124"><a href="/index.php/Table/News-Channels/Small-Molecules/" >Small Molecules</a></li><li class="item-125"><a href="/index.php/Table/News-Channels/Vaccines/" >Vaccines</a></li><li class="item-126"><a href="/index.php/Table/News-Channels/More-News/" >More News</a></li></ul></li><li class="item-116 deeper parent"><a href="/index.php/reports" >Reports</a><ul class="submenu sublevel-1"><li class="item-974"><a href="/index.php/reports" >All Products</a></li><li class="item-1108"><a href="/index.php/reports/antibody-protein-sales" >Antibody &amp; Protein Sales</a></li><li class="item-1109"><a href="/index.php/reports/antibody-technologies" >Antibody Technologies</a></li><li class="item-1110"><a href="/index.php/reports/biosimilar-antibodies-proteins" >Biosimilar Antibodies &amp; Proteins</a></li><li class="item-1111"><a href="/index.php/reports/car-t-cells-nk-cells" >CAR T-Cells &amp; NK Cells</a></li><li class="item-1112"><a href="/index.php/reports/immuno-oncology" >Immuno-Oncology</a></li><li class="item-1118"><a href="/index.php/reports/mrna-vaccines-therapeutics" >mRNA Vaccines &amp; Therapeutics</a></li><li class="item-1113"><a href="/index.php/reports/pipeline-database" >Pipeline Database </a></li><li class="item-1114"><a href="/index.php/reports/target-pipelines" >Target Pipelines</a></li><li class="item-1115"><a href="/index.php/reports/tcr-t-cells-and-antibodies" >TCR T-Cells and Antibodies</a></li><li class="item-1116"><a href="/index.php/reports/therapeutic-proteins-peptides" >Therapeutic Proteins &amp; Peptides</a></li><li class="item-1117"><a href="/index.php/reports/vaccines" >Vaccines</a></li></ul></li><li class="item-1119"><a href="https://lamerie.com/free-reports-list/" >FREE reports</a></li><li class="item-277"><a href="/index.php/Offers.html" >Offers</a></li><li class="item-118"><a href="/index.php/Table/Press-Room/" >Press Room</a></li><li class="item-119"><a href="/index.php/2005120240/About-Us.html" >About Us</a></li></ul>
</nav>
                
              </div>
            </div>      
          </div>
        </div>
      </div>
          
    </header>
    <div class="main-wrap">
      <div id="main-site" class="container">
                        
                  <div class="pathway row-fluid">
	<ul class="breadcrumb span12">
		<li><a href="/" class="pathway">Home</a></li> <img src="/media/system/images/arrow.png" alt=""  /> <li><a href="/index.php/News-Channels/" class="pathway">News Channels</a></li> <img src="/media/system/images/arrow.png" alt=""  /> <li><a href="/index.php/Table/News-Channels/DNA-RNA-and-Cells/" class="pathway">DNA, RNA &amp; Cells</a></li><span class="divider"><img src="/media/system/images/arrow.png" alt=""  /></span><li class="active">FDA Approves American Gene Technologies (AGT) to Move Forward with Phase 1 Clinical Trial of HIV Cure Program</li>	</ul>
</div>
                  
        <div class="row-fluid">
                <div class="span6 main-column">
          
          
                        <div class="" style="margin-top:-4px;">
              	<div class="moduletable ">
		<div class="mods">
			<div class="bghelper">
								<div class="modulcontent"><form action="/index.php/Table/News-Channels/DNA-RNA-and-Cells/" method="post">
	<div class="search search-bar ">
		<label for="mod-search-searchword"> </label><input name="searchword" id="mod-search-searchword" maxlength="255"  class="inputbox search-bar " type="text" size="255" value="Search in our News Channels..."  onblur="if (this.value=='') this.value='Search in our News Channels...';" onfocus="if (this.value=='Search in our News Channels...') this.value='';" /><input type="submit" value="Go" class="button search-bar " onclick="this.form.searchword.focus();"/>    <input type="hidden" name="areas[]" value="content" /> 
    <input type="hidden" name="area" value="content" />     
	<input type="hidden" name="task" value="search" />
	<input type="hidden" name="option" value="com_search" />
	<input type="hidden" name="Itemid" value="122" />
	</div>
</form>
</div>
			</div>
		</div>
	</div>
	
            </div>
              
                       
            
<div id="system-message-container">
</div>
                                                            			
			<div id="bd_results">
			<div id="cf_res_ajax_loader"></div><!-- Begin Content --> 
<article class="item-page">
		<h2>
			FDA Approves American Gene Technologies (AGT) to Move Forward with Phase 1 Clinical Trial of HIV Cure Program		</h2>


	
	

 <dl class="article-info">
 <dt class="article-info-term">Details</dt>
		<dd class="category-name">
										Category: <a href="/index.php/Table/News-Channels/DNA-RNA-and-Cells/">DNA RNA and Cells</a>						</dd>
		<dd class="published">
		Published on Tuesday, 11 August 2020 18:46		</dd>
		<dd class="hits">
		Hits: 1247		</dd>
 </dl>

	
		 <div class='joomla_add_this'><!-- AddThis Button BEGIN -->
<script type='text/javascript'>
var addthis_product = 'jlp-2.0';
var addthis_config = {
pubid:'ra-58627c4738199f53',
data_track_clickback:true,
ui_language:'en'
}
</script>
<div class="addthis_toolbox addthis_default_style addthis_32x32_style" addthis:url="https://pipelinereview.com/index.php/2020081175554/DNA-RNA-and-Cells/FDA-Approves-American-Gene-Technologies-AGT-to-Move-Forward-with-Phase-1-Clinical-Trial-of-HIV-Cure-Program.html" addthis:title="FDA Approves American Gene Technologies (AGT) to Move Forward with Phase 1 Clinical Trial of HIV Cure Program">
 <a class="addthis_button_facebook"></a>
 <a class="addthis_button_twitter"></a>
 <a class="addthis_button_email"></a>
 <a class="addthis_button_print"></a>
 <a class="addthis_button_addthis"></a>
</div><!-- AddThis Button END -->
</div><p><strong>ROCKVILLE, MD, USA I August 11, 2020 I <a href="https://www.globenewswire.com/Tracker?data=VSzJFWNdgIAQ_RpWsfNA8GO-j9MzjRs20Fg2emXIe-gea2SxN2qVLsJ8TXQ0nTEO3J_BEt0jVxzwq7wku9jhlMVYEGHUXvlkoZKECqte_30ArajyhSV6nLlaYfMSHn8U" target="_blank">American&nbsp;Gene Technologies&nbsp;(AGT)</a></strong>&nbsp;announced today approval by the FDA (Food and Drug Administration) to begin Phase 1, the first human clinical trial for AGT&rsquo;s lead <a href="https://www.globenewswire.com/Tracker?data=bbN2zlQ0Fl7vjjPxiOYC6xwrRgbX46U8l2SsK4U5sO-wc8Uj2dtdSUK_xNGQd37oRETbn5pE8S1sMLKLkOI54dZvJ__K6--3HniNcaemOMU=" target="_blank">HIV program</a>. AGT will conduct its Phase 1 study at clinical sites in the Baltimore/D.C. area, and has named Washington Health Institute, University of Maryland, Institute of Human Virology and Georgetown University as its initial trial sites. These sites are expected to begin enrollment in September 2020.&nbsp; AGT hopes to report initial data before the end of the year.</p>
<p>AGT&rsquo;s Phase 1 trial will investigate the safety of AGT103-T, measure key biomarkers and explore surrogate markers of efficacy. AGT103-T is a single-dose, lentiviral vector-based gene therapy developed to eliminate HIV from the millions of people globally infected with the disease.</p>
<p>HIV has affected society for more than four decades. Globally, nearly 38 million people have been infected with HIV and over one million people in the United States are living with HIV. So far, efforts to cure the disease have been unsuccessful. AGT developed a new treatment to repair immune system damage done by HIV and allow natural responses to control the virus. From its research, AGT believes a cure is attainable and is now taking the significant step of testing in humans.</p>
<p>The AGT103-T cell product is made from blood cells using an 11-day process that increases the HIV-fighting T cells and uses a gene therapy to help these cells survive in the body. The product demonstrates the ability to clear itself of HIV when challenged with the virus and HIV-infected human cells.</p>
<p>AGT&rsquo;s characterization of AGT103-T was done in collaboration with government researchers from the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health.&nbsp; Under a Collaborative Research Agreement, NIAID provided detailed characterization of CD4 T cells in the company&rsquo;s AGT103-T cell product and insight into mechanisms of action for this biological drug that may benefit people living with HIV.</p>
<p>A peer-reviewed article co-authored by AGT and NIAID scientists was published in Molecular Therapy in June 2020 (<a href="https://www.globenewswire.com/Tracker?data=lcOM0LawkS5wlx1FThZnkPMa-rq5SWTEk182HSYeer9wn_atK0HSxXnibCQiaW-1IK0b7jQtwru6HwJtj56X-KKOaAZTyUojkEG7lmfEAqq-kJbt-4PWWuikKzjZVPW7rwZTRYvZxBnroCexNGbzVvYlLe08ISQmoRoRLe0uWu674jLpGRxu9MjJViZ_rqCgMziCNL3UR6ckKvALE6FNOeixTbqhYLug2LC93KgbuM_E9m0RAoykJN0kTB7Rv33SDJk0zD9urZBq-elATsciFvZA-17yA44mak7HfkFy4EA=" target="_blank">read published article</a>). The publication describes the evolution of the AGT103-T manufacturing process as researchers developed the large-scale production of modified HIV-specific CD4 T cells that resist infection and depletion by HIV. The upcoming Phase 1 study will allow AGT to examine the effect of AGT103-T in a clinical setting which was previously demonstrated in preclinical human cell models.</p>
<p><em>The levels of potency in the AGT103-T cell product that have been repeated and validated by NIAID have given AGT further confidence that antiretroviral therapy-free HIV remission could be achieved soon. According to AGT founder and CEO</em><strong> Jeff Galvin,</strong> &ldquo;I am confident&nbsp;<a href="https://www.globenewswire.com/Tracker?data=57PPGFfeesKLGB-enTWNtZsynGs04adqKOhzIb3cWOKpVFPsGaLW02OVfEbiG_OWNOJn6ekqPnC14bbZAJP9Htzz73Rc3rvwUyVIYa6EX2J9kPOVOdIzh7q0u39qi7EV" target="_blank">AGT103-T</a>&nbsp;will be an important step towards an eventual cure for HIV.&rdquo;</p>
<p>"This is momentous news that we have FDA approval to launch Phase 1 and conduct our first human trials. We are beyond excited to reach this milestone. This brings us closer to our goal of transforming lives with genetic medicines,&rdquo; said Chief Science Officer David Pauza, Ph.D. &ldquo;Based on our successful commercial-scale product manufacturing runs and features of the product observed in our labs, this therapy has a high potential to be effective.&rdquo;</p>
<p><strong>Phase 1 in Maryland </strong></p>
<p>Maryland ranked fifth of all U.S. states and territories in HIV diagnosis rates, with nearly 1,000 new cases in 2018 alone according to the Maryland State Department of Health. The Washington, D.C. metropolitan area, including Baltimore, is a hotspot for HIV/AIDS.&nbsp; Our clinical trial sites in the metro area will test our new treatment in populations hardest hit by HIV.</p>
<p><strong>About HIV</strong></p>
<p>Today, approximately 37.9 million people worldwide and 1.2 million people in the United States&nbsp;are living with HIV/AIDS. The U.S. government has estimated that 38,900 Americans were newly infected with HIV in 2018 and 1.7 million individuals globally were infected with HIV in 2018. Locally, the Washington D.C./Baltimore area is often cited as a &lsquo;hot spot&rsquo; for HIV with Washington, D.C. having the highest rate of infection at nearly 48 infections per 100,000 population and Baltimore City with similarly high infection rates of 36 per 100,000.</p>
<p>Since the late 1980s, antiretroviral drugs have restored quality of life to persons living with HIV and, in some cases, have even been used to prevent new infections. However, no approved treatments can cure HIV. This is an unmet medical need that AGT is closer to addressing.</p>
<p><strong>About AGT 103-T</strong></p>
<p><a href="https://www.globenewswire.com/Tracker?data=57PPGFfeesKLGB-enTWNtaajRPMW-gtRc4TxIWbu93DwmoGGJ58J8J5-VAI6Ldct7QV0_gq0sC44s3CLnpNuDaWzFFRglAKgLeTZU8wfkm7HZnn4YaTbM2eKMhlje--r" target="_blank">AGT103-T</a>&nbsp;is a genetically-modified cell product made from a person's own cells. AGT's approach is unique in that it focuses on repairing the key immune system damage caused by HIV. When HIV infection causes this specific damage, killing of T helper cells required for immunity to HIV, the infected person becomes unable to eliminate the virus and thus, becomes chronically infected. AGT's approach is designed to repair the T helper cell defect and provide durable virus control that is not compromised by HIV strains that vary in sequence or use alternate ways to enter and infect T cells. AGT's&nbsp;<a href="https://www.globenewswire.com/Tracker?data=57PPGFfeesKLGB-enTWNtboLjHHZ8ZfANh2BPkdPYX1xUhp2uX15j-Oe3DsASit6p9KrhVK5FVY2MMCAPIm05w5x8wNlBu45AZu-1L0qXwc-ESFnR_90wY7nlslcGODz" target="_blank">AGT103-T</a>&nbsp;HIV therapeutic drug should work to remove infected cells from the body and decrease or eliminate the need for lifelong antiretroviral treatment.</p>
<p><strong>About American Gene Technologies (AGT)</strong></p>
<p><a href="https://www.globenewswire.com/Tracker?data=VSzJFWNdgIAQ_RpWsfNA8GO-j9MzjRs20Fg2emXIe-i97QtXZu3ka-q9jXyM3VO9KEgn3awikMe3QM2ZtQx2Qv1fkMQpT5uJnmHBHTq3v9I5_9oH8nkvEiztwYAS9z1j" target="_blank">American&nbsp;Gene Technologies&nbsp;(AGT)</a>&nbsp;is a gene and cell therapy company with a proprietary gene-delivery platform for rapid development of cell and gene therapies to cure infectious diseases, cancers, and inherited disorders. AGT's mission is to transform people's lives through genetic medicines that rid the body of disease. AGT has received 3 patents for the technology used to make the AGT103-T cell product and ten patents for its unique&nbsp;<a href="https://www.globenewswire.com/Tracker?data=RQ1KKlHRoFWF5eDA3P0LCdW5Pvdnz_PSG4ZxJP-P2pkCFzvb06Xbyx9SzPnxUaAV9wCy4oxIIxI9MnJKV1tJBSqZLamQGZCsy5syuUuYlVkPuPRDkB1nIvQh7CwXq4EY8QqcDRi6ZkdeFkcnQNDPTceY59UEYmUwUyj2FL7gvRU_M4HKmRlGqK3U6fQ4sRk2" target="_blank">immuno-oncology approach</a>&nbsp;to stimulate&nbsp;<a href="https://www.globenewswire.com/Tracker?data=rvtIfmaQFy9bPwJit6URt7vyH5AWa3Dy7O8zwL5esPoBKpm3WFbnRieTEjEy-t1eqidamm00E3oh8LVMLJ2wBOs8oWF04KeXfAL5e-NrxrAtQ_5ZVQF6467B2dph2e7weuhppoNcn6L6ToNUSGVqt0ym5Jp1fBzVUO7OFf1AzmX6MPb-j79virDEluiTi3Mu" target="_blank">gamma-delta (&gamma;&delta;) T cells</a>&nbsp;to destroy a variety of solid tumors. The company has developed a synthetic gene for treating<a href="https://www.globenewswire.com/Tracker?data=bX8wjTz-AWz4tX4NRA9Y4Qq3kr1c7rwv0apoQ0U3PWmRMJ_xlOLVTOH8vp3v7pGNHGUhPq2ooTZ-OUUHUgOfOi6p_fSFTBwWRhyKadmWAN2fmEKuZQ24Lri6-9WneBNaMEoC_u0IoE5nFlr1L3IB0gnxT1tOM5-GsiiZ9I8s9E8=" target="_blank">&nbsp;Phenylketonuria (PKU)</a>, a debilitating inherited disease. AGT's treatment for PKU has been granted&nbsp;<a href="https://www.globenewswire.com/Tracker?data=rPe2HJedtKssaDTF4V2knIgBZmYN4V-BU3srU3eOBWYgbIKK30PMNEHcx8vzBLNBf1TtcYPyL07l1MqwpiLNxOLj1NQmLDdiVWO_smY0zI6-6skZn5sK-0Acwm8MNxDfWdTmpq3p81myUvNni7Eac0v20Lblw76_seueuSnCNtt2qfHTBtv4S_mAGj9yOcEKeRyE2v0WPO0k38lDq6idchhQRPcwWXBiPyzFxTLfBVw=" target="_blank">Orphan Drug Designation</a>&nbsp;by the Food and Drug Administration (FDA), and it is expected to reach the clinic in 2020.</p>
<p><strong>SOURCE:</strong> American Gene Technologies</p> 
				<ul class="pagenav">
					<li class="pagenav-prev">
						<a href="/index.php/2020081375563/DNA-RNA-and-Cells/NS-Pharmas-VILTEPSO-viltolarsen-injection-Now-FDA-Approved-in-the-U.S.-for-the-Treatment-of-Duchenne-Muscular-Dystrophy-in-Patients-Amenable-to-Exon-53-Skipping-Therapy.html" rel="prev">&lt; Prev</a>
					</li>
					<li class="pagenav-next">
						<a href="/index.php/2020081175545/DNA-RNA-and-Cells/Arrowhead-Pharmaceuticals-Initiates-Dosing-Phase-1/2-Study-of-ARO-ENaC-for-Treatment-of-Cystic-Fibrosis.html" rel="next">Next &gt;</a>
					</li>
				</ul>
	
	</article></div>
         
         
                        
          </div>  
                              <div class="span3 left-mod hidden-phone">
            	<div class="moduletable ">
		<div class="mods">
			<div class="bghelper">
								<div class="modulcontent"><form action="/index.php/Table/News-Channels/DNA-RNA-and-Cells/" method="post">
	<div class="search search-bar ">
		<input name="searchword" id="mod-search-searchword" maxlength="255"   class="inputbox search-bar " type="text" size="255" value="Search in the store..."  onblur="if (this.value=='') this.value='Search in the store...';" onfocus="if (this.value=='Search in the store...') this.value='';" /><input type="submit" value="Go" class="button search-bar " onclick="this.form.searchword.focus();"/>    <input type="hidden" name="areas[]" value="virtuemart" /> 
    <input type="hidden" name="area" value="virtuemart" />     
	<input type="hidden" name="task" value="search" />
	<input type="hidden" name="option" value="com_search" />
	<input type="hidden" name="Itemid" value="122" />
	</div>
</form>
</div>
			</div>
		</div>
	</div>
		<div class="moduletable cart">
		<div class="mods">
			<div class="bghelper">
									<h3>Shopping cart</h3>
								<div class="modulcontent">
<!-- Virtuemart 2 Ajax Card -->
<div class="vmCartModule cart" id="vmCartModule">
	<div id="hiddencontainer" style=" display: none; ">
		<div class="container">
						  <div class="prices" style="float: right;"></div>
						<div class="product_row">
				<span class="product_name"></span>
			</div>

			<div class="product_attributes"></div>
		</div>
	</div>
	<div class="vm_cart_products">
		<div class="container">

				</div>
	</div>

<div class="total" style="float: right;">
	</div>
<div class="total_products">Cart empty</div>
<div class="show_cart">
	</div>
<div style="clear:both;"></div>

<noscript>
Please wait</noscript>
</div>

</div>
			</div>
		</div>
	</div>
		<div class="moduletable ">
		<div class="mods">
			<div class="bghelper">
									<h3>Latest report</h3>
								<div class="modulcontent">

<div class="custom"  >
	<p><a href="https://lamerie.com/report/masked-antibodies-cytokines-as-prodrugs-a-landscape-analysis-of-stakeholders-technologies-pipelines-business-and-financing-from-an-industry-perspective/">Masked Antibodies &amp; Cytokines As Prodrugs: a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective</a></p></div>
</div>
			</div>
		</div>
	</div>
		<div class="moduletable ">
		<div class="mods">
			<div class="bghelper">
									<h3>Featured Products</h3>
								<div class="modulcontent">

<div class="custom"  >
	<div class="vmproduct">
<div>
<p><a href="https://lamerie.com/report/vectorized-antibodies-for-in-vivo-expression-by-dna-and-mrna-a-landscape-analysis-of-stakeholders-technologies-targets-business-and-financing-from-an-industry-perspective/">Vectorized Antibodies for In Vivo Expression by DNA and mRNA: a landscape analysis of stakeholders, technologies, targets, business and financing from an industry perspective</a></p>
<p class="product_title entry-title"><a href="https://lamerie.com/report/targeted-protein-degradation-by-novel-protacs-and-molecular-glues-2020-a-landscape-analysis-of-companies-technologies-targets-investors-and-partners-from-an-industry-perspective/">Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective</a></p>
<p><a href="https://lamerie.com/report/rna-targeted-small-molecules-2019-a-landscape-analysis-of-companies-technologies-targets-investors-and-partners-from-an-industry-perspective/">RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective</a></p>
</div>
</div></div>
</div>
			</div>
		</div>
	</div>
		<div class="moduletable ">
		<div class="mods">
			<div class="bghelper">
									<h3>Latest Target Pipeline</h3>
								<div class="modulcontent">

<div class="custom"  >
	<p style="line-height: 115%;"><strong><a href="https://lamerie.com/report/sting-agonists-antagonists-target-pipeline-list-04-2020/">STING Agonists &amp; Antagonists</a></strong></p></div>
</div>
			</div>
		</div>
	</div>
	
          </div>
            
                    <div class="span3 left-mod visible-phone">
            	<div class="moduletable ">
		<div class="mods">
			<div class="bghelper">
								<div class="modulcontent"><form action="/index.php/Table/News-Channels/DNA-RNA-and-Cells/" method="post">
	<div class="search search-bar ">
		<input name="searchword" id="mod-search-searchword" maxlength="255"   class="inputbox search-bar " type="text" size="255" value="Search in the store..."  onblur="if (this.value=='') this.value='Search in the store...';" onfocus="if (this.value=='Search in the store...') this.value='';" /><input type="submit" value="Go" class="button search-bar " onclick="this.form.searchword.focus();"/>    <input type="hidden" name="areas[]" value="virtuemart" /> 
    <input type="hidden" name="area" value="virtuemart" />     
	<input type="hidden" name="task" value="search" />
	<input type="hidden" name="option" value="com_search" />
	<input type="hidden" name="Itemid" value="122" />
	</div>
</form>
</div>
			</div>
		</div>
	</div>
		<div class="moduletable cart">
		<div class="mods">
			<div class="bghelper">
									<h3>Shopping cart</h3>
								<div class="modulcontent">
<!-- Virtuemart 2 Ajax Card -->
<div class="vmCartModule cart" id="vmCartModule">
	<div id="hiddencontainer" style=" display: none; ">
		<div class="container">
						  <div class="prices" style="float: right;"></div>
						<div class="product_row">
				<span class="product_name"></span>
			</div>

			<div class="product_attributes"></div>
		</div>
	</div>
	<div class="vm_cart_products">
		<div class="container">

				</div>
	</div>

<div class="total" style="float: right;">
	</div>
<div class="total_products">Cart empty</div>
<div class="show_cart">
	</div>
<div style="clear:both;"></div>

<noscript>
Please wait</noscript>
</div>

</div>
			</div>
		</div>
	</div>
		<div class="moduletable ">
		<div class="mods">
			<div class="bghelper">
									<h3>Latest report</h3>
								<div class="modulcontent">

<div class="custom"  >
	<p><a href="https://lamerie.com/report/masked-antibodies-cytokines-as-prodrugs-a-landscape-analysis-of-stakeholders-technologies-pipelines-business-and-financing-from-an-industry-perspective/">Masked Antibodies &amp; Cytokines As Prodrugs: a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective</a></p></div>
</div>
			</div>
		</div>
	</div>
		<div class="moduletable ">
		<div class="mods">
			<div class="bghelper">
									<h3>Featured Products</h3>
								<div class="modulcontent">

<div class="custom"  >
	<div class="vmproduct">
<div>
<p><a href="https://lamerie.com/report/vectorized-antibodies-for-in-vivo-expression-by-dna-and-mrna-a-landscape-analysis-of-stakeholders-technologies-targets-business-and-financing-from-an-industry-perspective/">Vectorized Antibodies for In Vivo Expression by DNA and mRNA: a landscape analysis of stakeholders, technologies, targets, business and financing from an industry perspective</a></p>
<p class="product_title entry-title"><a href="https://lamerie.com/report/targeted-protein-degradation-by-novel-protacs-and-molecular-glues-2020-a-landscape-analysis-of-companies-technologies-targets-investors-and-partners-from-an-industry-perspective/">Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective</a></p>
<p><a href="https://lamerie.com/report/rna-targeted-small-molecules-2019-a-landscape-analysis-of-companies-technologies-targets-investors-and-partners-from-an-industry-perspective/">RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective</a></p>
</div>
</div></div>
</div>
			</div>
		</div>
	</div>
		<div class="moduletable ">
		<div class="mods">
			<div class="bghelper">
									<h3>Latest Target Pipeline</h3>
								<div class="modulcontent">

<div class="custom"  >
	<p style="line-height: 115%;"><strong><a href="https://lamerie.com/report/sting-agonists-antagonists-target-pipeline-list-04-2020/">STING Agonists &amp; Antagonists</a></strong></p></div>
</div>
			</div>
		</div>
	</div>
	
          </div>
                    
                    <div class="span3 right-mod">
            	<div class="moduletable light center">
		<div class="mods">
			<div class="bghelper">
								<div class="modulcontent">

<div class="customlight center"  >
	<h3>La Merie Biologics</h3>
<h4>FREE Weekly News Bulletin</h4>
<p><a href="https://lamerie.com/newsletter-signup/" class="btn btn-danger">Sign Up</a></p></div>
</div>
			</div>
		</div>
	</div>
		<div class="moduletable yellow center">
		<div class="mods">
			<div class="bghelper">
								<div class="modulcontent">

<div class="customyellow center"  >
	<h4 style="text-align: center; font-size: 19px;"><strong>2020 Sales of</strong><span style="font-size: 24px; display: block; margin-top: 6px;">Antibodies &amp; Proteins<span></span></span></h4>
<div style="text-align: center;"><a href="https://lamerie.com/report/2020-sales-of-recombinant-therapeutic-antibodies-proteins-biosimilars-other-biologics/" class="btn btn-danger">Get it now</a></div></div>
</div>
			</div>
		</div>
	</div>
		<div class="moduletable light center">
		<div class="mods">
			<div class="bghelper">
								<div class="modulcontent">

<div class="customlight center"  >
	<h3>New Product Alert</h3>
<h4>For La Merie Publishing</h4>
<p><a href="https://lamerie.com/newsletter-signup/" class="btn btn-danger">Sign Up</a></p></div>
</div>
			</div>
		</div>
	</div>
	
          </div>
                    
        </div>
                  
      </div>
    </div>
    <div class="vp-navigation-top container">
      <div id="scroll-top" title="Back to top">Top</div>
    </div>        
      
    <footer id="footer">
      <div class="container">
        <div class="inner-container">
          <div class="row-fluid">
            <ul class="list -line">
<li class="item-175"><a href="/index.php/2012051731797/Terms-and-Conditions.html" >Terms and Conditions</a></li><li class="item-176"><a href="/index.php/20120517591/Privacy-Policy.html" >Privacy Policy</a></li><li class="item-177"><a href="/index.php/2005120242/Submit-your-Press-Release.html" >Submit your Press Release</a></li><li class="item-180"><a href="/index.php/2012051744/Imprint.html" >Imprint</a></li></ul>


<div class="custom"  >
	<p style="text-align: center;">PipelineReview.com is powered by La Merie Business Intelligence <img src="/images/lamerie-footer.png" alt="La Merie Business Intelligence" width="110" height="40" style="vertical-align: middle; display: block; margin-left: auto; margin-right: auto;" /></p>
<p style="text-align: center;">For immediate assistance, please call us during business hours: Mon-Fri 10:00am - 05:00pm; GMT+01</p>
<p style="text-align: center;" align="center">La Merie Publishing - Ulrich Martin | Carrer Garraf, 20, Bajos, 1a | 08870 Sitges | Spain <br /> T +49-7934-6839 668 | F +49-3212-1267 572 | Email <span id="cloak592">This email address is being protected from spambots. You need JavaScript enabled to view it.</span><script type='text/javascript'>
 //<!--
 document.getElementById('cloak592').innerHTML = '';
 var prefix = '&#109;a' + 'i&#108;' + '&#116;o';
 var path = 'hr' + 'ef' + '=';
 var addy592 = '&#105;nf&#111;' + '&#64;';
 addy592 = addy592 + 'l&#97;m&#101;r&#105;&#101;' + '&#46;' + 'c&#111;m';
 document.getElementById('cloak592').innerHTML += '<a ' + path + '\'' + prefix + ':' + addy592 + '\'>' + addy592+'<\/a>';
 //-->
 </script></p>
<p align="center">All contents &copy; by La Merie Publishing</p>
<p align="center"><!-- GeoTrust QuickSSL [tm] Smart  Icon tag. Do not edit. --> <!-- end  GeoTrust Smart Icon tag --></p></div>

            
            
            <script src="https://assurance.sysnetgs.com/assurancecard/be8e7fbc4499573f6e4c0195ed268e8fb4841c7fec4fb4b1f12a7aaa0b3525c6/cardJs" type="text/javascript"></script>
          </div>  
        </div>    
      </div>      
    </footer>  
  </div>
  
<script type="text/javascript">
		(function($){
		$(document).ready(function () {
		$.cookieCuttr(
		{
    	cookieOverlayEnabled: false,
    	cookieNotificationLocationBottom: true,    	
     	cookieAnalytics: true,   	
		cookieCutter: true,    	
		cookieMessage: 'We use cookies for the proper functioning of this website. No personal details are stored. Read our <a href="/{{cookiePolicyLink}}" >Privacy Policy</a>',
		cookieAnalyticsMessage: 'We use cookies for the proper functioning of this website. No personal details are stored. Read our <a href="/{{cookiePolicyLink}}" >Privacy Policy</a>',
		cookiePolicyLink: 'index.php/20120517591/Privacy-Policy.html',
		cookieDeclineButton: true,
        cookieAcceptButtonText: 'ACCEPT COOKIES',
        cookieDeclineButtonText: 'DECLINE COOKIES',
		cookieDisable: '#comments',
		cookieDomain: 'pipelinereview.com',		
		cookieErrorMessage: 'See Docs to correctly format your message',
        cookieResetButton: false,
        cookieResetButtonText: 'Reset Cookies for this website',
		});
		});
		})(jQuery);

		if (jQuery.cookie('cc_cookie_accept') == 'cc_cookie_accept') {
   
		  var _gaq = _gaq || [];
		  _gaq.push(['_setAccount', 'UA-67947-2']);
		  _gaq.push(['_trackPageview']);
		
		  (function() {
		    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
		    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
		    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
		 })();
		  
  		}
		</script>

</body>
</html>

